Company Monitoring Page for JNJ

latest headlines for company on cafepharma

13 drugmakers contracted by Operation Warp Speed in 2020
Beckers Hospital Review
Wed, 12/16/20 - 10:36 pm
Tags:
HHS, Operation Warp Speed, COVID-19, vaccines, Cytiva, Eli Lilly, AstraZeneca, Emergent BioSolutions, Fujifilm, JNJ, Moderna Therapeutics, Pfizer, BioNTech, Novavax, Regeneron, Sanofi, GSK
[video+transcript]The Next Big Catalysts to Watch in the COVID Vaccine Race
Motley Fool
Sat, 12/12/20 - 02:20 pm
Tags:
vaccines, COVID-19, AstraZeneca, JNJ, Novavax
AstraZeneca, J&J COVID-19 shots must succeed to meet U.S. vaccination goal: Slaoui
Fierce Pharma
Thu, 12/10/20 - 07:16 pm
Tags:
COVID-19, vaccines, AstraZeneca, JNJ
Johnson & Johnson cuts size of Covid-19 vaccine study due to prevalence of disease in U.S.
Stat
Wed, 12/9/20 - 11:02 pm
Tags:
JNJ, clinical trials, COVID-19, vaccines
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Motley Fool
Wed, 12/9/20 - 10:55 am
Tags:
vaccines, COVID-19, Pfizer, Moderna Therapeutics, AstraZeneca, JNJ
J&J taps the bispecific experts at Xencor for prostate cancer discovery pact, kicking off with $50M upfront
Endpoints
Mon, 12/7/20 - 10:45 am
Tags:
JNJ, Xencor, Janssen, bispecific antibodies, prostate cancer
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
Sun, 12/6/20 - 07:15 pm
Tags:
AstraZeneca, BeiGene, JNJ, AbbVie, Calquence, Brukinsa, Imbruvica, CLL, ASH2020
ASH: J&J links subcut BCMA bispecific to 73% response rate, plots aggressive investment
Fierce Biotech
Sun, 12/6/20 - 07:10 pm
Tags:
ASH2020, JNJ, bispecifics, Multiple Myeloma, teclistamab
In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA
Fierce Biotech
Thu, 12/3/20 - 10:55 am
Tags:
Janssen, non-small cell lung cancer, FDA, amivantamab, JNJ, metastatic non-small cell lung cancer
Janssen buys up eye disorder gene therapy asset from Hemera Biosciences
Fierce Biotech
Wed, 12/2/20 - 10:45 am
Tags:
Janssen, JNJ, Hemera Biosciences, gene therapy, HMR59, geographic atrophy
Pfizer, Moderna apply for EMA authorization; Janssen's candidate begins rolling review
RAPS.org
Tue, 12/1/20 - 11:45 pm
Tags:
Pfizer, Moderna Therapeutics, Emergency Use Authorization, FDA, vaccines, JNJ, Janssen
Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race
Motley Fool
Tue, 12/1/20 - 11:07 am
Tags:
JNJ, Moderna Therapeutics, BioNTech, Pfizer, vaccines, COVID-19
3D Printing Helps J&J’s Ethicon Design Prisma Health’s Ventilator in 10 Days
Medical Devices and Diagnostics Industry
Mon, 11/30/20 - 11:32 pm
Tags:
3D printing, JNJ, Ethicon, ventilators, Prisma Health, devices, pandemic, COVID-19
Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'
Fierce Pharma
Wed, 11/25/20 - 10:41 am
Tags:
JNJ, Janssen, DTC advertising, corporate branding
J&J tries to strike the right note with Ottava
EP Vantage
Mon, 11/23/20 - 10:12 am
Tags:
JNJ, robotic surgery, devices, Medtech, Intuitive Surgical, Ottava
Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna
Motley Fool
Fri, 11/20/20 - 11:02 am
Tags:
Pfizer, BioNTech, Moderna Therapeutics, COVID-19, vaccines, BNT162b2, mRNA-1273, JNJ, AstraZeneca
J&J, following BMS, pledges $100M to address racism and health inequities
Fierce Pharma
Tue, 11/17/20 - 11:04 pm
Tags:
JNJ, racism
J&J, erring on caution, tests new 2-dose regimen for COVID-19 vaccine
Fierce Biotech
Mon, 11/16/20 - 10:42 am
Tags:
JNJ, COVID-19, vaccines, clinical trials
J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial
Endpoints
Mon, 11/16/20 - 10:24 am
Tags:
JNJ, BARDA, COVID-19, vaccines, clinical trials
J&J tops list of healthcare supply chains amid COVID vaccine effort—and Pfizer wins kudos, too
Fierce Pharma
Sat, 11/14/20 - 01:55 pm
Tags:
JNJ, COVID-19, vaccines, supply chain, Pfizer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.